Jazz Pharmaceuticals PLC

Samantha Pearce to Retire as Jazz Pharmaceuticals' Chief Commercial Officer

TradingView · 11 d ago

Jazz Pharmaceuticals Price Target Cut to $296.00/Share From $299.00 by RBC Capital

Dow Jones Newswires · 11 d ago

Nuvation, Jazz gain new Buys at Citi on oncology prospects

Seeking Alpha · 19 d ago

Weekly Recap: Term Loan B restructured and $337 target for JAZZ

TradingView · 22 d ago

Nvidia-backed AI drugmaker Iambic Therapeutics seeks U.S. listing

seekingalpha · 28 d ago

JAZZ Rises on Updated OS Results From Gastric Cancer Study

zacks · 48 d ago

Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

stockstory · 49 d ago

Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio

PRNewsWire · 71 d ago

Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term

Zacks Investment Research · 74 d ago

JAZZ vs. TECH: Which Stock Is the Better Value Option?

Zacks Investment Research · 75 d ago

Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results

PRNewsWire · 77 d ago